168 related articles for article (PubMed ID: 37226786)
1. Conditioned Media Therapy in Alzheimer's Disease: Current Findings and Future Challenges.
Firoozi A; Shadi M; Aghaei Z; Namavar MR
Curr Stem Cell Res Ther; 2024; 19(5):700-711. PubMed ID: 37226786
[TBL] [Abstract][Full Text] [Related]
2. Stem cell-conditioned medium is a promising treatment for Alzheimer's disease.
Alidoust L; Akhoondian M; Atefi AH; Keivanlou MH; Hedayati Ch M; Jafari A
Behav Brain Res; 2023 Aug; 452():114543. PubMed ID: 37311523
[TBL] [Abstract][Full Text] [Related]
3. Stem Cells in Alzheimer's Disease: Current Standing and Future Challenges.
Salem H; Colpo GD; Teixeira AL
Adv Exp Med Biol; 2018; 1079():93-102. PubMed ID: 29767290
[TBL] [Abstract][Full Text] [Related]
4. Conditioned medium from the stem cells of human dental pulp improves cognitive function in a mouse model of Alzheimer's disease.
Mita T; Furukawa-Hibi Y; Takeuchi H; Hattori H; Yamada K; Hibi H; Ueda M; Yamamoto A
Behav Brain Res; 2015 Oct; 293():189-97. PubMed ID: 26210934
[TBL] [Abstract][Full Text] [Related]
5. Stem cell therapy for Alzheimer's disease.
Abdel-Salam OM
CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):459-85. PubMed ID: 21495961
[TBL] [Abstract][Full Text] [Related]
6. Hypoxic-conditioned medium from adipose tissue mesenchymal stem cells improved neuroinflammation through alternation of toll like receptor (TLR) 2 and TLR4 expression in model of Alzheimer's disease rats.
Mehrabadi S; Motevaseli E; Sadr SS; Moradbeygi K
Behav Brain Res; 2020 Feb; 379():112362. PubMed ID: 31739000
[TBL] [Abstract][Full Text] [Related]
7. Adipose tissue-derived stem cells as a potential candidate in treatment of Alzheimer's disease: A systematic review on preclinical studies.
Madani Neishaboori A; Eshraghi A; Tasouji Asl A; Shariatpanahi M; Yousefifard M; Gorji A
Pharmacol Res Perspect; 2022 Aug; 10(4):e00977. PubMed ID: 35718918
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cell therapies for Alzheimer's disease: preclinical studies.
Zhao X; Li D; Zhang L; Niu Y; Wang W; Niu B
Metab Brain Dis; 2021 Oct; 36(7):1687-1695. PubMed ID: 34213730
[TBL] [Abstract][Full Text] [Related]
9. Stem cells in the treatment of Alzheimer's disease - Promises and pitfalls.
Bhatti JS; Khullar N; Mishra J; Kaur S; Sehrawat A; Sharma E; Bhatti GK; Selman A; Reddy PH
Biochim Biophys Acta Mol Basis Dis; 2023 Aug; 1869(6):166712. PubMed ID: 37030521
[TBL] [Abstract][Full Text] [Related]
10. Stem cell treatment for Alzheimer's disease.
Li M; Guo K; Ikehara S
Int J Mol Sci; 2014 Oct; 15(10):19226-38. PubMed ID: 25342318
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal Stem Cell Therapy and Alzheimer's Disease: Current Status and Future Perspectives.
Kim J; Lee Y; Lee S; Kim K; Song M; Lee J
J Alzheimers Dis; 2020; 77(1):1-14. PubMed ID: 32741816
[TBL] [Abstract][Full Text] [Related]
12. Stem Cell Therapies in Alzheimer's Disease: Applications for Disease Modeling.
Si Z; Wang X
J Pharmacol Exp Ther; 2021 May; 377(2):207-217. PubMed ID: 33558427
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal Stem Cell-Conditioned Medium Improves Mitochondrial Dysfunction and Suppresses Apoptosis in Okadaic Acid-Treated SH-SY5Y Cells by Extracellular Vesicle Mitochondrial Transfer.
Zhang Z; Sheng H; Liao L; Xu C; Zhang A; Yang Y; Zhao L; Duan L; Chen H; Zhang B
J Alzheimers Dis; 2020; 78(3):1161-1176. PubMed ID: 33104031
[TBL] [Abstract][Full Text] [Related]
14. Promoted CD4
Wu X; Shen Q; Chang H; Li J; Xing D
J Neuroinflammation; 2022 Oct; 19(1):253. PubMed ID: 36217178
[TBL] [Abstract][Full Text] [Related]
15. Adipose-derived stem cell-conditioned medium ameliorates antidepression-related behaviors in the mouse model of Alzheimer's disease.
Yamazaki H; Jin Y; Tsuchiya A; Kanno T; Nishizaki T
Neurosci Lett; 2015 Nov; 609():53-7. PubMed ID: 26472709
[TBL] [Abstract][Full Text] [Related]
16. Melatonin-pretreated adipose-derived mesenchymal stem cells efficeintly improved learning, memory, and cognition in an animal model of Alzheimer's disease.
Nasiri E; Alizadeh A; Roushandeh AM; Gazor R; Hashemi-Firouzi N; Golipoor Z
Metab Brain Dis; 2019 Aug; 34(4):1131-1143. PubMed ID: 31129766
[TBL] [Abstract][Full Text] [Related]
17. Conditioned medium from amniotic fluid mesenchymal stem cells could modulate Alzheimer's disease-like changes in human neuroblastoma cell line SY-SY5Y in a paracrine manner.
Hasanpour M; Rahbarghazi R; Nourazarian A; Khaki-Khatibi F; Avci ÇB; Hassanpour M; Talebi M; Taghavi H; Salimi L
Tissue Cell; 2022 Jun; 76():101808. PubMed ID: 35526311
[TBL] [Abstract][Full Text] [Related]
18. Regenerative medicine improve neurodegenerative diseases.
Ashraf SS; Hosseinpour Sarmadi V; Larijani G; Naderi Garahgheshlagh S; Ramezani S; Moghadamifar S; Mohebi SL; Brouki Milan P; Haramshahi SMA; Ahmadirad N; Amini N
Cell Tissue Bank; 2023 Sep; 24(3):639-650. PubMed ID: 36527565
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal stem cell-derived extracellular vesicles: a glimmer of hope in treating Alzheimer's disease.
Liew LC; Katsuda T; Gailhouste L; Nakagama H; Ochiya T
Int Immunol; 2017 Jan; 29(1):11-19. PubMed ID: 28184439
[TBL] [Abstract][Full Text] [Related]
20. Engrafted stem cell therapy for Alzheimer's disease: A promising treatment strategy with clinical outcome.
Salwa ; Kumar L
J Control Release; 2021 Oct; 338():837-857. PubMed ID: 34509587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
